The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $35.74

Today's change0.00 0.00%
Updated December 8 4:00 PM EST. Delayed by at least 15 minutes.
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $35.74

Today's change0.00 0.00%
Updated December 8 4:00 PM EST. Delayed by at least 15 minutes.

Pfizer Inc closed at (U.S.)$35.74.

Shares have lost 1.68% over the last five days, but sit 2.83% below their 52-week high. This security has underperformed the S&P 500 by 2.53% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $35.74
  • High--
  • Low--
  • Bid / Ask(U.S.) $35.62 / (U.S.) $35.80
  • YTD % change+10.04%
  • Volume402
  • Average volume (10-day)15,534,907
  • Average volume (1-month)15,137,952
  • Average volume (3-month)16,293,941
  • 52-week range(U.S.) $30.51 to (U.S.) $36.78
  • Beta0.99
  • Trailing P/E21.95×
  • P/E 1 year forward13.78×
  • Forward PEG2.32×
  • Indicated annual dividend(U.S.) $1.28
  • Dividend yield3.58%
  • Trailing EPS(U.S.) $1.63
Updated December 8 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 01, 201710/01/2017Jul 02, 201707/02/2017Apr 02, 201704/02/2017Dec 31, 201612/31/2016
Revenue13,16812,89612,77913,628
Total other revenue--------
Total revenue13,16812,89612,77913,628
Gross profit10,34710,24210,30610,414
Total cost of revenue2,8212,6542,4733,214
Total operating expense9,5648,8878,55212,706
Selling / general / administrative3,5003,4253,3084,423
Research & development1,8591,7801,7082,512
Depreciation / amortization1,1771,2081,1861,122
Interest expense (income), net operating--------
Unusual expense (income)504981961,500
Other operating expenses, total-297-278-319-65
Operating income3,6044,0094,227922
Interest income (expense), net non-operating-340-331-325-312
Gain (loss) on sale of assets167349590
Other--------
Income before tax3,5853,8153,951776
Income after tax2,8583,0763,130847
Income tax, total727739821-71
Net income2,8403,0733,121858
Total adjustments to net income------1
Net income before extra. items2,8403,0713,121841
Minority interest-18-5-9-6
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,8403,0713,121842
Inc. avail. to common incl. extra. items2,8403,0733,121859
Diluted net income2,8403,0733,121859
Dilution adjustment----0--
Diluted weighted average shares6,0416,0376,0926,144
Diluted EPS excluding extraordinary itemsvalue per share0.470.510.510.14
Dividends per sharevalue per share0.320.320.320.30
Diluted normalized EPSvalue per share0.510.520.520.36